Free Trial

Gritstone bio (GRTS) News Today

$0.07
+0.01 (+17.06%)
(As of 10/15/2024 ET)
Gritstone bio, Inc. (NASDAQ:GRTS) Short Interest Up 13.6% in September
Why Gritstone Bio (GRTS) Stock Is Down 64% Today
Key Takeaways From Gritstone Bio Analyst Ratings
Gritstone bio, Inc. stock logo
Gritstone bio (NASDAQ:GRTS) Downgraded by JMP Securities to Market Perform
JMP Securities lowered shares of Gritstone bio from an "outperform" rating to a "market perform" rating in a research report on Tuesday.
Gritstone bio, Inc. stock logo
Gritstone bio, Inc. (NASDAQ:GRTS) Short Interest Down 8.5% in August
Gritstone bio, Inc. (NASDAQ:GRTS - Get Free Report) was the recipient of a large drop in short interest in August. As of August 15th, there was short interest totalling 7,180,000 shares, a drop of 8.5% from the July 31st total of 7,850,000 shares. Approximately 6.6% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,420,000 shares, the days-to-cover ratio is presently 5.1 days.
Gritstone bio, Inc. stock logo
HC Wainwright Comments on Gritstone bio, Inc.'s Q3 2024 Earnings (NASDAQ:GRTS)
Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Research analysts at HC Wainwright lifted their Q3 2024 earnings estimates for shares of Gritstone bio in a research report issued on Thursday, August 15th. HC Wainwright analyst S. Lee now anticipates that the company will earn ($0.14) per share
Gritstone bio, Inc. stock logo
Gritstone bio (NASDAQ:GRTS) Releases Earnings Results, Beats Estimates By $0.12 EPS
Gritstone bio (NASDAQ:GRTS - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.16) earnings per share for the quarter, beating analysts' consensus estimates of ($0.28) by $0.12. Gritstone bio had a negative net margin of 926.13% and a negative return on equity of 232.42%. The business had revenue of $0.92 million during the quarter, compared to analysts' expectations of $2.77 million.
Gritstone bio, Inc. stock logo
Gritstone bio (NASDAQ:GRTS) Given Market Outperform Rating at JMP Securities
JMP Securities reaffirmed a "market outperform" rating and issued a $5.00 price objective on shares of Gritstone bio in a report on Monday.
Get Gritstone bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRTS and its competitors with MarketBeat's FREE daily newsletter.

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

GRTS Media Mentions By Week

GRTS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GRTS
News Sentiment

0.31

0.80

Average
Medical
News Sentiment

GRTS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GRTS Articles
This Week

8

4

GRTS Articles
Average Week

Get Gritstone bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRTS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GRTS) was last updated on 10/16/2024 by MarketBeat.com Staff
From Our Partners